Switch to:
More From Other Websites
Is XBI Heading Back to Where It Started in April? Apr 28 2016
Opportunities For Xtandi, Medivation’s Key Drug Apr 28 2016
Energy-Related Stocks Rose after FOMC Decision Apr 27 2016
Trader's Notebook: Responding to the Move in Dollar Futures Apr 25 2016
Trader's Notebook: Searching for Bullish Excess in the Banks Apr 22 2016
Rising Dollar Offsets Crude Prices as Major SPDR Indexes Fall Apr 21 2016
XBI’s Large Caps: BioMarin Gives Update on Gene Therapy Study Apr 21 2016
How Does XBI Compare to Its 100-Day Moving Average? Apr 21 2016
XBI Mid-Caps: Medivation Rose after Rejecting Sanofi’s Takeover Bid Apr 20 2016
SPDR Indexes across Energy and Gold Rise on Increase in Commodities Apr 19 2016
What Do Analysts Recommend for Medivation? Apr 19 2016
Return Of The Mack: This Biotech ETF Is Back Apr 19 2016
Recovery in Crude Prices Lifts Energy and Healthcare SPDR Indexes Apr 18 2016
US Dollar Is Strong despite Inflation Releasing below Forecast Apr 14 2016
Analyst Estimates for Ionis Pharmaceuticals’ 2016 Revenue Apr 14 2016
Large-Cap News: Edwards Surged on SAPIENT 3 TAVR Data Apr 11 2016
Among Biotechnology ETFs, XBI Dominated the 1st Week of April Apr 11 2016
XBI Mid Caps: Alnylam to Present at Needham Healthcare Conference Apr 08 2016
Incyte Continues Its Growth Spree in 2015 Apr 07 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK